rediff.com
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sales 74.57 58.83 20.49 11.20 11.85
Operating profit 19.40 5.36 2.89 1.44 1.54
Interest 0.29 0.28 0.29 0.03 -
Gross profit 21.93 6.28 2.68 1.77 1.55
EPS (Rs) 16.93 4.02 4.79 0.22 0.23
Annual  results in details
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Other income 2.82 1.20 0.08 0.36 0.01
Stock adjustment 0.70 -0.33 -0.73 -0.19 -0.26
Raw material 13.38 11.35 11.08 2.95 3.33
Power and fuel - - - - -
Employee expenses 5.65 4.89 4.90 4.07 4.40
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 35.44 37.56 2.35 2.93 2.84
Provisions made - - - - -
Depreciation 2.05 1.84 1.66 1.47 1.48
Taxation 1.35 0.04 0.27 0.06 0.14
Net profit / loss 18.54 4.41 0.75 0.03 0.04
Extra ordinary item - - - -0.20 0.10
Prior year adjustments - - - - -
Equity capital 10.95 10.96 1.57 1.57 1.57
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 26.02 9.12 14.09 12.90 13.00
GPM (%) 28.34 10.46 13.03 15.29 13.06
NPM (%) 23.95 7.34 3.65 0.29 0.30
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close